BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18330030)

  • 21. Immunoadsorption for coagulation factor inhibitors: a retrospective critical appraisal of 10 consecutive cases from a single institution.
    Rivard GE; St Louis J; Lacroix S; Champagne M; Rock G
    Haemophilia; 2003 Nov; 9(6):711-6. PubMed ID: 14750937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).
    Hay CR; Baglin TP; Collins PW; Hill FG; Keeling DM
    Br J Haematol; 2000 Oct; 111(1):78-90. PubMed ID: 11091185
    [No Abstract]   [Full Text] [Related]  

  • 23. Haemophilia part 1: an introduction.
    Khair K
    Br J Nurs; 2013 Jun 13-26; 22(11):620. PubMed ID: 23899729
    [No Abstract]   [Full Text] [Related]  

  • 24. Specific therapy in hemophilia.
    Hutaff LW
    N C Med J; 1973 Mar; 34(3):193-6. PubMed ID: 4510809
    [No Abstract]   [Full Text] [Related]  

  • 25. The maintenance of tolerance after successful immune tolerance induction in hemophilia A and B: the North American Registry. Factor VIII/IX Subcommittee of the International Society for Thrombosis and Hemostasis.
    DiMichele D; Kroner B;
    Haematologica; 2000 Oct; 85(10 Suppl):40-2; discussion 42-4. PubMed ID: 11187869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The North American Immune Tolerance Registry: practices, outcomes, outcome predictors.
    DiMichele DM; Kroner BL;
    Thromb Haemost; 2002 Jan; 87(1):52-7. PubMed ID: 11848456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemophilia].
    Shima M
    Rinsho Ketsueki; 2013 Feb; 54(2):189-97. PubMed ID: 23470826
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular biology of coagulation.
    Pavirani A; Bischoff R
    Schweiz Med Wochenschr Suppl; 1991; 43():55-7. PubMed ID: 1843038
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibitors in congenital coagulation disorders.
    Key NS
    Br J Haematol; 2004 Nov; 127(4):379-91. PubMed ID: 15521914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery.
    Shapiro AD; Gilchrist GS; Hoots WK; Cooper HA; Gastineau DA
    Thromb Haemost; 1998 Nov; 80(5):773-8. PubMed ID: 9843170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hemophilia. New aspects in diagnosis and treatment].
    Gormsen J
    Ugeskr Laeger; 1973 Nov; 135(46):2487-93. PubMed ID: 4592776
    [No Abstract]   [Full Text] [Related]  

  • 32. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
    Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
    Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advances in the field of hemophilia therapy].
    Loeliger EA; Veltkamp JJ
    Ned Tijdschr Geneeskd; 1968 Sep; 112(36):1593-5. PubMed ID: 5680135
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of the bleeding inhibitor patient.
    Astermark J
    Semin Thromb Hemost; 2003 Feb; 29(1):77-86. PubMed ID: 12640569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substitution treatment of hemophilia a and b.
    Duckert F
    Schweiz Med Wochenschr; 1975 Jun; 105(24):783-4. PubMed ID: 1145162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristics of the diagnosis, clinical aspects and treatment of hemophilias with specific, circulating anticoagulants].
    Barkagan ZS; Sukhoveeva EIa; Eremin GF; Tolochko OI; Shevchenko VI
    Probl Gematol Pereliv Krovi; 1972 Apr; 17(4):35-41. PubMed ID: 4680852
    [No Abstract]   [Full Text] [Related]  

  • 37. Hemophilia care in China: review of care for 417 hemophilia patients from 11 treatment centers in Shanxi Province.
    Zhao H; Yang L; Long C; Guo Y; Wu R; Liu X; Qin X; Liang H; Duan Z
    Expert Rev Hematol; 2015 Aug; 8(4):543-50. PubMed ID: 25948487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent improvements in the clinical treatment of coagulation factor inhibitors.
    Franchini M; Lippi G
    Semin Thromb Hemost; 2009 Nov; 35(8):806-13. PubMed ID: 20169517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An inhibitor of antihemophilic factor (factor VIII) in an 18-month-old nonhemophilic child.
    Stein J; Ratnoff OD
    Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):346-50. PubMed ID: 8328652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolving Complexity in Hemophilia Management.
    Croteau SE
    Pediatr Clin North Am; 2018 Jun; 65(3):407-425. PubMed ID: 29803274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.